Fund Subscribed by Asymchem Laboratories' Unit Completes Establishment; HK, Shenzhen Shares Up 3%

MT Newswires Live07-22

Asymchem Laboratories (Tianjin) (HKG:6821, SHE:002821) subsidiary, Ailiying Life Science Technology (Tianjin), has participated in a new medical and health industry investment fund, according to a Saturday filing on the Shenzhen Stock Exchange.

The fund, officially named Tianjin Haihe Ailiying Medical and Health Industry Investment Fund Partnership (Limited Partnership), completed its filing procedures with the Asset Management Association of China.

The Chinese pharmaceutical company contributed 300 million yuan to the fund, along with other entities, the filing added.

Shares of the company rose around 3% in Shenzhen and Hong Kong in recent trading.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2453012787?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-07-22 12:17","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2453012787","market":"us","top_or_hot":-1,"title":"Fund Subscribed by Asymchem Laboratories' Unit Completes Establishment; HK, Shenzhen Shares Up 3%","media":"MT Newswires Live","content":"<html><body><p> Asymchem Laboratories (Tianjin) (HKG:6821, SHE:002821) subsidiary, Ailiying Life Science Technology (Tianjin), has participated in a new medical and health industry investment fund, according to a Saturday filing on the Shenzhen Stock Exchange.</p><p>The fund, officially named Tianjin Haihe Ailiying Medical and Health Industry Investment Fund Partnership (Limited Partnership), completed its filing procedures with the Asset Management Association of China.</p><p>The Chinese pharmaceutical company contributed 300 million yuan to the fund, along with other entities, the filing added.</p><p>Shares of the company rose around 3% in Shenzhen and Hong Kong in recent trading.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Fund Subscribed by Asymchem Laboratories' Unit Completes Establishment; HK, Shenzhen Shares Up 3%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFund Subscribed by Asymchem Laboratories' Unit Completes Establishment; HK, Shenzhen Shares Up 3%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-07-22 12:17 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Asymchem Laboratories (Tianjin) (HKG:6821, SHE:002821) subsidiary, Ailiying Life Science Technology (Tianjin), has participated in a new medical and health industry investment fund, according to a ...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2453012787","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2453012787","pubTimestamp":1721621876,"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Asymchem Laboratories   subsidiary, Ailiying Life Science Technology , has participated in a new medical and health industry investment fund, according to a Saturday filing on the Shenzhen Stock Exchange.The fund, officially named Tianjin Haihe Ailiying Medical and Health Industry Investment Fund Partnership , completed its filing procedures with the Asset Management Association of China.The Chinese pharmaceutical company contributed 300 million yuan to the fund, along with other entities, the filing added.Shares of the company rose around 3% in Shenzhen and Hong Kong in recent trading.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"凯莱英医药子公司认缴的基金完成设立；香港、深圳股市上涨3%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06821":1,"002821":0.9},"content_text":"Asymchem Laboratories (Tianjin) (HKG:6821, SHE:002821) subsidiary, Ailiying Life Science Technology (Tianjin), has participated in a new medical and health industry investment fund, according to a Saturday filing on the Shenzhen Stock Exchange.The fund, officially named Tianjin Haihe Ailiying Medical and Health Industry Investment Fund Partnership (Limited Partnership), completed its filing procedures with the Asset Management Association of China.The Chinese pharmaceutical company contributed 300 million yuan to the fund, along with other entities, the filing added.Shares of the company rose around 3% in Shenzhen and Hong Kong in recent trading.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2453012787"}